Keith Brownlie
Fortune : 24 782 $ au 30/06/2026
Fortune : 24 782 $ au 30/06/2026
Mr. Keith L.
Brownlie, CPA, is an Independent Director at Celldex Therapeutics, Inc. and a Member at The American Institute of Certified Public Accountants.
He is on the Board of Directors at Celldex Therapeutics, Inc. and Trek Therapeutics PBC.
Mr. Brownlie was previously employed as an Independent Director by Phio Pharmaceuticals Corp., an Independent Director by EpiCept Corp., an Independent Director by Soligenix, Inc., an Audit Partner by Ernst & Young LLP, and a Vice President & Trustee by New Jersey Society of Certified Public Accountants.
He also served on the board at Cancer Genetics, Inc. He received his undergraduate degree from Lehigh University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/06/2026 | 666 ( 0 % ) | 24 782 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/06/2017 |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Trek Therapeutics PBC
Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Manufactures medicines for infectious diseases | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Directeur/Membre du Conseil | 10/10/2019 |
| SOLIGENIX, INC. | Directeur/Membre du Conseil | 06/09/2019 |
| CANCER GENETICS, INC. | Directeur/Membre du Conseil | 08/12/2014 |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Directeur/Membre du Conseil | 21/08/2013 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01/01/2010 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Soligenix, Inc.
Soligenix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes biodefense vaccines and oral therapeutic products | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Cancer Genetics, Inc.
Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Provides cancer diagnostics and clinical services | Health Technology |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
New Jersey Society of Certified Public Accountants
New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Commercial Services |
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. BiotechnologyHealth Technology Develops RNAi-based medical technologies and therapies | Health Technology |
Trek Therapeutics PBC
Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Manufactures medicines for infectious diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national